Effects of fentanyl on cellular immune functions in man

International Journal of Immunopharmacology

Volumn 21, Issue 7, 1999, Pages 445-454

  Jacobs, Roland ^a   Karst, Matthias ^a   Scheinichen, Dirk ^a   Bevilacqua, Carmine ^a   Schneider, Udo ^a   Heine, Jörn ^a   Schedlowski, Manfred ^b   Schmidt, Reinhold E ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Fentanyl; Granulocytes; Lymphocyte subpopulations; NK cell trafficking; Opioid

Indexed keywords

FENTANYL; NALOXONE; OPIATE AGONIST; PLACEBO; SUPEROXIDE;

ADULT; ARTICLE; B LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOCYTE SUBPOPULATION; MALE; NATURAL KILLER CELL; NORMAL HUMAN; PERIPHERAL LYMPHOCYTE; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; RESPIRATORY BURST; T LYMPHOCYTE;

ADULT; ANALGESICS, OPIOID; BLOOD PRESSURE; FENTANYL; HEART RATE; HUMANS; IMMUNITY, CELLULAR; IMMUNOPHENOTYPING; KILLER CELLS, NATURAL; LEUKOCYTE COUNT; LEUKOCYTES, MONONUCLEAR; MALE; RESPIRATORY BURST;

EID: 0033020567     PISSN: 01920561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0192-0561(99)00025-9     Document Type: Article

References (45)

1. Garcia Penarrubia P., Koster F.T., Kelley R.O., McDowell T.D., Bankhurst A.D. Antibacterial activity of human natural killer cells. J Exp Med. 169:1989;99-113.
2. Hatcher M.R., Kuhn R.E. Destruction of Trypanosoma cruzi by natural killer cells. Science. 218:1982;295.
3. Zarling J.M., Yasukawa M. Autologous herpes simplex virus-infected cells are lysed by human natural killer cells. J Immunol. 131:1983;2011-2016.
4. Janeway C.A. Natural killer cells: a primitive immune system. Nature. 341:1989;108.
5. Schmidt R.E., Macdermott R.P., Bartley G., Bertovich M., Amato D.A., Austen K.F., Schlossman S.F., Stevens R.L., Ritz J. Specific release of proteoglycans from human natural killer cells during target lysis. Nature. 318:1985;289-291.
6. Tagasuki M., Mickey M.R., Terasaki P.I. Reactivity of lymphocytes from normal persons on cultured tumor cells. Cancer Res. 33:1973;2898-2902.
7. Trinchieri G. Biology of natural killer cells. Adv Immunol. 47:1989;187-376.
8. Kurago Z.B., Smith K.D., Lutz C.T. NK cell recognition of MHC class I. NK cells are sensitive to peptide-binding groove and surface alpha-helical mutations that affect T cells. J Immunol. 154:1995;2631-2641.
9. Lanier L.L., Phillips J.H. Inhibitory MHC class I receptors on NK cells and T cells. Immunol Today. 17:1996;86-91.
10. Phillips J.H., Chang C., Mattson J., Gumperz J.E., Parham P., Lanier L.L. CD94 and a novel associated protein (94AP) form a NK cell receptor involved in the recognition of HLA-A, HLA-B, and HLA-C allotypes. Immunity. 5:1996;163-172.
11. Pedersen B.K., Tvede N., Hansen F.R., Andersen V., Bendix T., Bendixen G., Bendtzen K., Galbo H., Haahr P.M., Klarlund K., Sylvest J., Thomsen B.S., Halkjaer-Kristensen J. Modulation of natural killer cell activity in peripheral blood by physical exercise. Scand J Immunol. 27:1988;673-678.
12. Schedlowski M., Jacobs R., Stratmann G., Richter S., Hadicke A., Tewes U., Wagner T.O., Schmidt R.E. Changes of natural killer cells during acute psychological stress. J Clin Immunol. 13:1993;119-126.
13. Benschop R.J., Nijkamp F.P., Ballieux R.E., Heijnen C.J. The effects of beta-adrenoceptor stimulation on adhesion of human natural killer cells to cultured endothelium. Br J Pharmacol. 113:1994;1311-1316.
14. Benschop R.J., Jacobs R., Sommer B., Schurmeyer T.H., Raab J.R., Schmidt R.E., Schedlowski M. Modulation of the immunologic response to acute stress in humans by beta-blockade or benzodiazepines. FASEB J. 10:1996;517-524.
15. Schedlowski M., Falk A., Rohne A., Wagner T.O., Jacobs R., Tewes U., Schmidt R.E. Catecholamines induce alterations of distribution and activity of human natural killer (NK) cells. J Clin Immunol. 13:1993;344-351.
16. Schedlowski M., Hosch W., Oberbeck R., Benschop R.J., Jacobs R., Raab H.R., Schmidt R.E. Catecholamines modulate human NK cell circulation and function via spleen-independent beta 2-adrenergic mechanisms. J Immunol. 156:1996;93-99.
17. Blalock J.E. The syntax of immune-neuroendocrine communication. Immunol Today. 15:1994;504-511.
18. Kavelaars A., Ballieux R.E., Heijnen C.J. In vitro beta-adrenergic stimulation of lymphocytes induces the release of immunoreactive beta-endorphin. Endocrinology. 126:1990;3028-3032.
19. Wiegent D.A., Blalock J.E. Interactions between the neuroendocrine and immune systems: common hormones and receptors. Immunol Rev. 100:1987;79-108.
20. Wakefield C.H., Carey P.D., Foulds S., Monson J.R., Guillou P.J. Polymorphonuclear leukocyte activation. An early marker of the postsurgical sepsis response. Arch Surg. 128:1993;390-395.
21. Wakefield C.H., Carey P.D., Foulds S., Monson J.R., Guillou P.J. Surgery and the release of a neutrophil Fc gamma receptor. Am J Surg. 170:1995;277-284.
22. Boyum A. Separation of lymphocytes from blood and bone marrow. Scan J Clin Lab Invest. 21:1968;97-107.
23. Heine J., Leuwer M., Scheinichen D., Arseniev L., Jaeger K., Piepenbrock S. Flow cytometry evaluation of the in vitro influence of four i.v. anaesthetics on respiratory burst of neutrophils. Br J Anaesth. 77:1996;387-392.
24. Rothe G., Oser A., Valet G. Dihydrorhodamine 123: a new flow cytometric indicator for respiratory burst activity in neutrophil granulocytes. Naturwissenschaften. 75:(7):1988;354-355.
25. + natural killer cells after bone marrow transplantation. Blood. 79:1992;3239-3244.
26. Fung D.L., Eisele J.H. Fentanyl pharmacokinetics in awake volunteers. J Clin Pharmacol. 20:1980;652-658.
27. Chuang L.F., Chuang T.K., Killam K.F. Jr, Chuang A.J., Kung H.F., Yu L., Chuang R.Y. Delta opioid receptor gene expression in lymphocytes. Biochem Biophys Res Commun. 202:1994;1291-1299.
28. Johnson H.M., Torres B.A. Complementary peptides as probes to explore neuropeptide receptors on lymphocytes. Immunomethods. 5:1994;167-171.
29. Morgan E.L. Regulation of human B lymphocyte activation by opioid peptide hormones. Inhibition of IgG production by opioid receptor class (mu-, kappa-, and delta-) selective agonists. J Neuroimmunol. 65:1996;21-30.
30. Fields A., Sarne Y. The stimulatory effect of opioids on cyclic AMP production in SK-N-SH cells is mediated by calcium ions. Life Sci. 61:1997;595-602.
31. Sarne Y., Rubovitch V., Fields A., Gafni M. Dissociation between the inhibitory and stimulatory effects of opioid peptides on cAMP formation in SK-N-SH neuroblastoma cells. Biochem Biophys Res Commun. 246:1998;128-131.
32. Krumholz W., Demel C., Jung S., Meuthen G., Hempelmann G. The influence of fentanyl and alfentanil on functions of human polymorphonuclear leukocytes in vitro. Acta Anaesthesiol Scand. 37:1993;386-389.
33. Krumholz W., Endrass J., Knecht J., Hempelmann G. The effects of midazolam, droperidol, fentanyl, and alfentanil on phagocytosis and killing of bacteria by polymorphonuclear leukocytes in vitro. Acta Anaesthesiol Scand. 39:1995;624-627.
34. Benschop R.J., Rodriguez-Feuerhahn M., Schedlowski M. Catecholamine-induced leukocytosis: early observations, current research, and future directions. Brain Behav Immun. 10:1996;77-91.
35. Benschop R.J., Schedlowski M., Wienecke H., Jacobs R., Schmidt R.E. Adrenergic control of natural killer cell circulation and adhesion. Brain Behav Immun. 11:1997;321-332.
36. Tandonnet F., Bourgain J.L., Mcgee K., Comoy E., Truffa-Bachi J. Hemodynamic and catecholamine response to isoflurane vs droperidol in complement to fentanyl anaesthesia. Acta Anaesthesiol Scand. 35:1991;123-128.
37. Tolksdorf W., Schafer E., Pfeiffer J., Mittelstaedt G. Behavior of adrenaline, noradrenaline, blood pressure and heart rate in intubation in relation to different doses of fentanyl. Anasth Intensivther Notfallmed. 22:1987;171-176.
38. Shavit Y., Lewis J.W., Terman G.W., Gale R.P., Liebeskind J.C. Opioid peptides mediate the suppressive effect of stress on natural killer cell cytotoxicity. Science. 223:1984;188-190.
39. Shavit Y., Depaulis A., Martin F.C., Terman G.W., Pechnick R.N., Zane C.J., Gale R.P., Liebeskind J.C. Involvement of brain opiate receptors in the immune-suppressive effect of morphine. Proc Natl Acad Sci USA. 83:1986;7114-7117.
40. Beilin B., Shavit Y., Hart J., Mordashov B., Cohn S., Notti I., Bessler H. Effects of anesthesia based on large versus small doses of fentanyl on natural killer cell cytotoxicity in the perioperative period. Anesth Analg. 82:1996;492-497.
41. Yeager M.P., Colacchio T.A., Yu C.T., Hildebrandt L., Howell A.L., Weiss J., Guyre P.M. Morphine inhibits spontaneous and cytokine-enhanced natural killer cell cytotoxicity in volunteers. Anesthesiology. 83:1995;500-508.
42. Fecho K., Maslonek K.A., Dykstra L.A., Lysle D.T. Assessment of the involvement of central nervous system and peripheral opioid receptors in the immunomodulatory effects of acute morphine treatment in rats. J Pharmacol Exp Ther. 276:1996;626-636.
43. Weber R.J., Pert A. The periaqueductal gray matter mediates opiate-induced immunosuppression. Science. 245:1989;188-190.
44. Millar D.B., Hough C.J., Mazorow D.L., Gootenberg J.E. Beta-endorphin's modulation of lymphocyte proliferation is dose, donor, and time dependent. Brain Behav Immun. 4:1990;232-242.
45. Panerai A.E., Sacerdote P. Beta-endorphin in the immune system: a role at last? Immunol Today. 18:1997;317-319.